Skip to main content
Premium Trial:

Request an Annual Quote

Elucidating Medulloblastoma


In Nature this week, researchers at the Broad Institute, and their collaborators in the US, Canada, and Germany report their whole-exome profiling of 92 medulloblastoma samples and paired normal samples, and their identification of 12 gene mutations they say occurred at statistically significant frequencies. These include both previously known mutations and newly identified recurrent somatic mutations in the RNA helicase gene DDX3X. The study provides researchers with a list of biomarkers that could possibly be used to detect or treat medulloblastoma, the most common form of malignant brain tumors in children, says International Science Times' Amir Khan. The team found that these pediatric brain tumors mutate at a much lower rate than adult cancers. In a statement, study co-author Scott Pomeroy of Boston Children's Hospital notes that the mutations are clustered in genes that regulate the function of cells' growth pathways, but aren't directly involved in those pathways.

"Doctors used to categorize medulloblastoma patients as either standard or high-risk, depending on biopsy results," Khan adds. "However, more recently, researchers have found that medulloblastoma could be divided into four subcategories based on gene expression, each with survival rates ranging from 20 to 90 percent." Now, Pomeroy says, not only do researchers have a way of stratifying these tumors genetically, they also have a good idea of which gene mutations drive the different subtypes. "For the first time, we'll be able to classify and treat medulloblastoma based on molecular typing, providing the best therapy with the fewest long-term consequences," he adds.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.